Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19

被引:22
作者
Fagyas, Miklos [1 ,2 ]
Kertesz, Attila [2 ]
Siket, Ivetta Manyine [1 ]
Banhegyi, Viktor [1 ,3 ]
Kracsko, Bertalan [2 ,3 ]
Szegedi, Andrea [2 ,3 ]
Szokol, Miklos [2 ]
Vajda, Gusztav [2 ]
Racz, Ildiko [2 ,3 ]
Gulyas, Hajnalka [1 ,4 ]
Szkibak, Noemi [2 ]
Racz, Vivienn [2 ]
Csanadi, Zoltan [2 ]
Papp, Zoltan [1 ,5 ]
Toth, Attila [1 ,5 ]
Sipka, Sandor [2 ]
机构
[1] Univ Debrecen, Fac Med, Dept Cardiol, Div Clin Physiol, Debrecen, Hungary
[2] Univ Debrecen, Fac Med, Dept Cardiol, Debrecen, Hungary
[3] Univ Debrecen, Doctoral Sch Kalman Laki, Debrecen, Hungary
[4] Univ Debrecen, Doctoral Sch Pharmacol Sci, Debrecen, Hungary
[5] Hungarian Acad Sci, HAS UD Vasc Biol & Myocardial Pathophysiol Res Gr, Budapest, Hungary
关键词
ACE2; activity; Coronavirus disease 2019 (COVID-19); Aortic stenosis; SARS-CoV-2; Cardiovascular disease; CONVERTING ENZYME 2;
D O I
10.1007/s11357-020-00300-2
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Coronavirus disease 2019 (COVID-19) has a high mortality in elderly patients with pre-existing cardiovascular diseases. The cellular receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the angiotensin-converting enzyme 2 (ACE2), thereby implicating a link between cardiovascular diseases and SARS-CoV-2 susceptibility. Aortic stenosis (AS) represents a chronic inflammatory state with severe cardiovascular complications in the elderly, a prime condition for COVID-19 mortality. The circulating ACE2 levels were measured in 111 patients with severe AS and compared to patients with hypertension and healthy individuals. About 4 times higher circulating ACE2 activity was found in patients with severe AS than in hypertensives or healthy individuals (88.3 +/- 61.6., n = 111, 20.6 +/- 13.4, n = 540, and 16.1 +/- 7.4 mU/L, n = 46, respectively). Patients with severe AS were older than patients with hypertension (80 +/- 6 years vs. 60 +/- 15 years, P < 0.05). Serum ACE2 activity correlated negatively with the left ventricular ejection fraction, aortic root area, TAPSE, and positively with the right ventricular systolic pressure, cardiac diameters in patients with AS. In contrast, circulating ACE2 activity was independent of the blood pressure, peak flow velocity at the aortic root, kidney function (GFR), and inflammatory state (CRP). We found no effect of RAAS inhibitory drugs on the serum ACE2 activity in this group of patients. Our results illustrate circulating ACE2 as a potential interface between chronic inflammation, cardiovascular disease, and COVID-19 susceptibility. Elderly patients with AS have markedly elevated ACE2 levels together with altered left and right ventricular functions, which may pose higher risks during COVID-19. Our clinical data do not support a role for RAAS inhibitors in regulating circulating ACE2 levels.
引用
收藏
页码:19 / 29
页数:11
相关论文
共 26 条
[1]   Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? [J].
Batlle, Daniel ;
Wysocki, Jan ;
Satchell, Karla .
CLINICAL SCIENCE, 2020, 134 (05) :543-545
[2]   Structure analysis of the receptor binding of 2019-nCoV [J].
Chen, Yun ;
Guo, Yao ;
Pan, Yihang ;
Zhao, Zhizhuang Joe .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 525 (01) :135-140
[3]   Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease [J].
Cho, Kyoung Im ;
Sakuma, Ichiro ;
Sohn, Il Suk ;
Jo, Sang-Ho ;
Koh, Kwang Kon .
ATHEROSCLEROSIS, 2018, 277 :60-65
[4]   COVID-19 and Cardiovascular Disease [J].
Clerkin, Kevin J. ;
Fried, Justin A. ;
Raikhelkar, Jayant ;
Sayer, Gabriel ;
Griffin, Jan M. ;
Masoumi, Amirali ;
Jain, Sneha S. ;
Burkhoff, Daniel ;
Kumaraiah, Deepa ;
Rabbani, LeRoy ;
Schwartz, Allan ;
Uriel, Nir .
CIRCULATION, 2020, 141 (20) :1648-1655
[5]   Inflammation Is Associated with the Remodeling of Calcific Aortic Valve Disease [J].
Cote, Nancy ;
Mahmut, Ablajan ;
Bosse, Yohan ;
Couture, Christian ;
Page, Sylvain ;
Trahan, Sylvain ;
Boulanger, Marie-Chloe ;
Fournier, Dominique ;
Pibarot, Philippe ;
Mathieu, Patrick .
INFLAMMATION, 2013, 36 (03) :573-581
[6]   Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? [J].
Esler, Murray ;
Esler, Danielle .
JOURNAL OF HYPERTENSION, 2020, 38 (05) :781-782
[7]   New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) II: Albumin Suppresses Angiotensin Converting Enzyme (ACE) Activity in Human [J].
Fagyas, Miklos ;
Uri, Katalin ;
Siket, Ivetta M. ;
Fueloep, Gabor A. ;
Csato, Viktoria ;
Darago, Andrea ;
Boczan, Judit ;
Banyai, Emese ;
Szentkiralyi, Istvan Elek ;
Maros, Tamas Miklos ;
Szerafin, Tamas ;
Edes, Istvan ;
Papp, Zoltan ;
Toth, Attila .
PLOS ONE, 2014, 9 (04)
[8]   Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? [J].
Fang, Lei ;
Karakiulakis, George ;
Roth, Michael .
LANCET RESPIRATORY MEDICINE, 2020, 8 (04) :E21-E21
[9]   COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome [J].
Gattinoni, Luciano ;
Coppola, Silvia ;
Cressoni, Massimo ;
Busana, Mattia ;
Rossi, Sandra ;
Chiumello, Davide .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (10) :1299-1300
[10]   Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy Early Experience and Forecast During an Emergency Response [J].
Grasselli, Giacomo ;
Pesenti, Antonio ;
Cecconi, Maurizio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1545-1546